BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30980364)

  • 21. TNF Inhibitor Pomalidomide Sensitizes Glioblastoma Cells to EGFR Inhibition.
    Luo Z; Wang B; Liu H; Shi L
    Ann Clin Lab Sci; 2020 Jul; 50(4):474-480. PubMed ID: 32826244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
    J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
    Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor.
    Petri MK; Brobeil A; Planz J; Bräuninger A; Gattenlöhner S; Nestler U; Stenzinger A; Paradowska A; Wimmer M
    J Neurooncol; 2015 May; 123(1):15-25. PubMed ID: 25862004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.
    Guo G; Gong K; Ali S; Ali N; Shallwani S; Hatanpaa KJ; Pan E; Mickey B; Burma S; Wang DH; Kesari S; Sarkaria JN; Zhao D; Habib AA
    Nat Neurosci; 2017 Aug; 20(8):1074-1084. PubMed ID: 28604685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.
    Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A
    Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
    Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
    Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification.
    Yoshida Y; Ozawa T; Yao TW; Shen W; Brown D; Parsa AT; Raizer JJ; Cheng SY; Stegh AH; Mazar AP; Giles FJ; Sarkaria JN; Butowski N; Nicolaides T; James CD
    Mol Cancer Ther; 2014 Dec; 13(12):2919-29. PubMed ID: 25313012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.
    Sarkaria JN; Yang L; Grogan PT; Kitange GJ; Carlson BL; Schroeder MA; Galanis E; Giannini C; Wu W; Dinca EB; James CD
    Mol Cancer Ther; 2007 Mar; 6(3):1167-74. PubMed ID: 17363510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to Human cell glioblastoma apoptosis by platinum-maurocalcin conjugate.
    Aroui S; Dardevet L; Najlaoui F; Kammoun M; Laajimi A; Fetoui H; De Waard M; Kenani A
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):15-22. PubMed ID: 27210502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells.
    Buendia Duque M; Pinheiro KV; Thomaz A; da Silva CA; Freire NH; Brunetto AT; Schwartsmann G; Jaeger M; de Farias CB; Roesler R
    J Mol Neurosci; 2019 May; 68(1):49-57. PubMed ID: 30887411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.
    Li L; Huang Y; Gao Y; Shi T; Xu Y; Li H; Hyytiäinen M; Keski-Oja J; Jiang Q; Hu Y; Du Z
    BMC Cancer; 2018 Dec; 18(1):1215. PubMed ID: 30514230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
    Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.
    Alamdari-Palangi V; Karami Z; Karami H; Baazm M
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1747-1753. PubMed ID: 32592373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide.
    Ciechomska IA; Gielniewski B; Wojtas B; Kaminska B; Mieczkowski J
    Exp Mol Med; 2020 Aug; 52(8):1326-1340. PubMed ID: 32788653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A.
    Ganesan S; Unger BL; Comstock AT; Angel KA; Mancuso P; Martinez FJ; Sajjan US
    Thorax; 2013 Feb; 68(2):131-41. PubMed ID: 23099361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.